Skip to main content
DIACEUTICS PLC logo

DIACEUTICS PLC — Investor Relations & Filings

Ticker · DXRX ISIN · GB00BJQTGV64 LEI · 213800VEWQBB39ZB8J81 IL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 278 across all filing types
Latest filing 2022-05-05 Regulatory Filings
Country GB United Kingdom
Listing IL DXRX

About DIACEUTICS PLC

https://www.diaceutics.com/

Diaceutics PLC is a data analytics and end-to-end services provider focused on the development and commercialization of precision medicine diagnostics. The company supports pharmaceutical and biotech clients by providing solutions to improve the diagnostic testing ecosystem, aiming to ensure patients receive the correct personalized treatment. Its primary offering is DXRX, The Diagnostic Network®, a diagnostic commercialization platform for precision medicine. DXRX facilitates collaboration among stakeholders, including laboratories and pharmaceutical companies, in a secure marketplace and provides access to real-world diagnostic testing data. This integrated platform is designed to streamline the launch and adoption of new precision medicines.

Recent filings

Filing Released Lang Actions
Contract Win
Regulatory Filings Classification · 100% confidence The document is identified by the header 'RNS Number : 3692K' and concludes with standard boilerplate text referencing 'RNS, the news service of the London Stock Exchange' and the FCA. The content announces a specific business event: securing a 'US$1m+ contract with global pharma company for data feed from the DXRX platform'. This is a material, non-financial announcement made via the Regulatory News Service (RNS). Since it is a specific business update that doesn't fit into categories like Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP), and it is a direct announcement rather than a report itself, the most appropriate classification is the general regulatory announcement category, RNS.
2022-05-05 English
PDMR Shareholding/Share Incentive Plan
Remuneration Information Classification · 99% confidence The document is an RNS announcement dated April 29, 2022, detailing a transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014 concerning a Person Discharging Managerial Responsibilities (PDMR), Stefan Macdonald. Specifically, it reports the purchase of ordinary shares and a matched share award under the company's Share Incentive Plan (SIP). This type of filing, reporting personal share transactions by directors/executives, directly corresponds to the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the specific content mandates the DIRS classification over the general RNS fallback.
2022-04-29 English
Notice of AGM and Posting of Annual Report
Report Publication Announcement Classification · 100% confidence The document is a short announcement (2748 characters) released via RNS. The title explicitly states "Notice of AGM and Posting of Annual Report". It announces that the company is posting its Annual Report and the Notice of the 2022 Annual General Meeting (AGM) to shareholders and that these documents will be available on the website shortly. According to Rule 2 (The 'MENU VS MEAL' Rule), when a document is short and announces the publication of a report (like the Annual Report or AGM notice), it should be classified as a Report Publication Announcement (RPA) rather than the full report (10-K or AGM-R) itself. Since it announces both the AGM details and the Annual Report posting, RPA is the most appropriate classification for the announcement itself.
2022-04-28 English
Purchase and Sale of Shares and PDMR Shareholdings
Director's Dealing Classification · 99% confidence The document is an official announcement released via RNS (RNS Number : 5524H) on April 7, 2022. The content explicitly details 'Purchase and Sale of Shares and PDMR Shareholdings' for directors and persons discharging managerial responsibilities (PDMRs) of Diaceutics PLC, referencing Article 19(1) of Regulation (EU) No. 596/2014. This type of filing, reporting insider transactions by management, directly corresponds to the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the specific content mandates the DIRS classification over the general RNS fallback.
2022-04-07 English
PDMR Shareholding/Share Incentive Plan
Director's Dealing Classification · 99% confidence The document is an official notification released via RNS (Regulatory News Service) on April 6, 2022. The content explicitly details a 'PDMR Shareholding/Share Incentive Plan' transaction involving a director (Susanne Munksted) purchasing ordinary shares and receiving a matched award. This structure, including the reference to 'Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014', is the standard format for reporting insider transactions by company directors and executives. This directly corresponds to the definition for Director's Dealing (DIRS).
2022-04-06 English
Conversion of Convertible Loan Notes & TVR
Regulatory Filings Classification · 98% confidence The document is a formal announcement disseminated via RNS (Regulatory News Service), indicated by the 'RNS Number' header and the footer referencing RNS as the primary information provider approved by the FCA. The content details the 'Conversion of Convertible Loan Notes & Total Voting Rights,' specifically announcing the issuance of new ordinary shares following a debt conversion. This action directly impacts the company's capital structure and total issued share count. While it relates to capital changes (CAP) and share issuance (SHA), the primary nature of this specific RNS filing, which reports a change in total voting rights and is distributed through the official regulatory channel, fits best under the general 'Regulatory Filings' (RNS) category, as it is a mandatory disclosure of a material event via the designated service, rather than a detailed financing document (CAP) or a pure share issuance notice (SHA). Given the context of RNS distribution and the nature of the update, RNS is the most appropriate classification for this type of regulatory news release.
2022-04-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.